Interaction of tea tree oil with model and cellular membranes

Journal of Medicinal Chemistry

Volumn 49, Issue 15, 2006, Pages 4581-4588

  Giordani, Cristiano ^a   Molinari, Agnese ^a   Toccacieli, Laura ^a   Calcabrini, Annarica ^a   Stringaro, Annarita ^a   Chistolini, Pietro ^a   Arancia, Giuseppe ^a   Diociaiuti, Marco ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; DIPALMITOYLPHOSPHATIDYLCHOLINE; ESSENTIAL OIL; GLYCOPROTEIN P; LIPID; TEA TREE OIL;

ADSORPTION KINETICS; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; APOPTOSIS; ARTICLE; ARTIFICIAL MEMBRANE; AUSTRALIA; BREWSTER ANGLE MICROSCOPY; CANCER INHIBITION; CELL MEMBRANE; CELL ULTRASTRUCTURE; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG TRANSPORT; FLOW CYTOMETRY; FREEZE FRACTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; LANGMUIR BLODGETT FILM; LIPID MONOLAYER; LIPID RAFT; MELALEUCA; MELANOMA CELL; MEMBRANE STRUCTURE; MOLECULAR MIMICRY; MULTIDRUG RESISTANCE; STRUCTURE ANALYSIS; THERMODYNAMICS; TRANSMISSION ELECTRON MICROSCOPY;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; ADSORPTION; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; CELL MEMBRANE; CHOLESTEROL; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; FREEZE FRACTURING; G(M1) GANGLIOSIDE; HUMANS; MELANOMA; MEMBRANE MICRODOMAINS; MEMBRANES, ARTIFICIAL; MICROSCOPY, ELECTRON, TRANSMISSION; P-GLYCOPROTEIN; TEA TREE OIL; THERMODYNAMICS;

EID: 33746733556     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm060228i     Document Type: Article

References (42)

1. Brophy, J. J.; Davies, N. W.; Southwell, I. A.; Stiff I. A.; Williams, L. R. Gas chromatographic quality control for oil of Melaleuca terpinen-4-ol type (Australian tea tree). J. Agric. Food Chem. 1989, 37, 1330-1335.
2. Markham, J. L. Biological Activity of Tea Tree Oil. In Tea Tree, the Genus Melaleuca; Southwell I.; Lowe R., Eds.; Harwood Academic Publishers: Amsterdam, 1999; pp 169-190.
3. Carson, C. F.; Riley T. V. Antimicrobial activity of the major components of the essential oil of Melaleuca alternifolia. J. Appl. Bacteriol. 1995, 78, 264-269.
4. Southwell, I. A.; Hayes, A. J.; Markham, J. L.; Leach D. N. The search for optimally bioactive Australian tea tree oil. Acta Hortic. 1993, 334, 265-275.
5. Altman, P. M. Australian tea tree oil. Aust. J. Pharm. 1988, 69, 276-278.
6. Anderson, J. N.; Fennessy P. A. Can tea tree (Melaleuca alternifolia) oil prevent MRSA? Med. J. Aust. 2000, 173, 489-456.
7. Caelli, M.; Porteous J.; Carson, C. F.; Heller, R.; Riley, T. V. Tea tree oil as an alternative topical decolonization agent for methicillin-resistant Staphylococcus aureus. J. Hosp. Infect. 2000, 46, 236-237.
8. Carson, C. F.; Riley, T. V.; Cookson, B. D. Efficacy and safety of tea tree oil as a topical antimicrobial agent. J. Hosp. Infect. 1998, 40, 175-178.
9. May, J.; Chan, C. H.; King, A.; Williams, L.; French, G. L. Time-kill studies of tea tree oils on clinical isolates. J. Antimicrob. Chemother. 2000, 45, 639-643.
10. Zhang, S. Y.; Robertson, D. A study of tea tree oil ototoxicity. Audiol. Neurootol. 2000, 5, 64-68.
11. D'Auria, F. D.; Laino, L.; Strippoli, V.; Tecca, M.; Salvatore, G.; Battinelli, L.; Mazzanti, G. In vitro activity of tea tree oil against Candida albicans mycelial conversion and other pathogenic fungi. J. Chemother. 2001, 13, 377-83.
12. Ernst, E.; Huntley, A. Tea tree oil: a systematic review of randomized clinical trials. Forsch Komplementarmed Klass Naturheilkd 2000, 7, 17-20.
13. Nenoff, P.; Haustein, U.; Brandt, W. Antifungal activity of the essential oil of Melaleuca alternifolia (tea tree oil) against pathogenic fungi in vitro. Skin Pharmacol. 1996, 9, 388-394.
14. Syed, T. A.; Qureshi, Z. A.; Ali, S. M.; Ahmad, S.; Ahmad, S. A. Treatment of toenail onychomycosis with 2% butenafine and 5% Melaleuca alternifolia (tea tree) oil in cream. Trop. Med. Int. Health 1999, 4, 284-287.
15. Calcabrini, A.; Stringaro, A.; Toccacieli, L.; Meschini, S.; Marra, M.; Colone, M.; Salvatore, G.; Mondello, F.; Arancia, G.; Molinari, A. Terpinen-4-ol, the main component of Melaleuca alternifolia (tea tree) oil inhibits the in vitro growth of human melanoma cells. J. Invest. Dermatol. 2004, 122, 349-60.
16. Smyth, M. J.; Krasovskis, E.; Sutton, V. R.; Johnstone, R. W. The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 7024-7029.
17. Johnstone, R. W.; Cretne, y E.; Smyth, M. J. P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death. Blood 1999, 93, 1075-1085.
18. Gollapud, S.; Gupta, S. Anti-P-glycoprotein antibody-induced apoptosis of activated peripheral blood lymphocytes: a possible role of P-glycoprotein in lymphocyte survival. J. Clin. Immunol. 2001, 21, 420-430.
19. Singer, S. J.; Nicolson, G. L. The fluid mosaic model of the structure of cell membranes. Science 1972, 175, 730-731.
20. Thompson, T. E.; Tillack T. W. Organization of glycosphingolipids in bilayers and plasma membranes of mammalian cells. Annu. Rev. Biophys. Biophys. Chem. 1985, 14, 361-86.
21. Simons K.; Ikonen E. Functional rafts in cell membranes. Nature 1997, 387, 569-572.
22. Simons K.; Toomre D. Lipid rafts and signal transduction. Nature Rev. 2000, 1, 31-39.
23. Simons K.; Ikonen E. How cells handle cholesterol. Science 2000, 290, 1721-1726.
24. Rinia H. A.; de Kruijff B. Imaging domains in model membranes with atomic force microscopy. FEBS Lett. 2001, 25113, 1-6.
25. M1 in L-α-DPPC/Cholesterol monolayers: a model for lipid rafts. Biophys. J. 2000, 79, 2768-2781.
26. M1 in phosphatidylcholine and phosphatidylcholine/Cholesterol bilayers. Biophys. J. 2001, 81, 1059-1069.
27. M1 domains in sphingomyelin/DOPC/cholesterol membranes. Biophys. J. 2002, 82, 2526-2535.
28. Tsui-Pierchala B. A.; Encinas M.; Milbrandt J.; Johnson E. M. J. Lipid rafts in neuronal signaling and function. Trends Neurosci. 2002, 25, 412-417.
29. Lavie Y.; Fiucci G.; Czarny M.; Liscovitch M. Changes in membrane microdomains and caveolae constituents in multidrug-resistant cancer cells. Lipids 1999, 34, Suppl. S57-63.
30. Bacso Z.; Nagy H.; Goda K.; Bene L.; Fenyvesi F.; Matko J.; Szabo G. Raft and cytoskeleton associations of an ABC transporter: P-glycoprotein. Cytometry 2004, 61A, 105-116.
31. Troost J.; Lindenmaier H.; Haefeli W. E.; Weiss J. Modulation of cellular cholesterol alters P-glycoprotein activity in multidrug-resistant cells. Mol. Pharmacol. 2004, 66, 1332-1336.
32. Radeva G.; Perabo J.; Sharom F. J. P-Glycoprotein is localized in intermediate-density membrane microdomains distinct from classical lipid rafts and caveolar domains. FEBS J. 2005, 272, 4924-4937.
33. Diociaiuti M.; Bordi F.; Motta A.; Carosi A.; Molinari A.; Arancia G.; Coluzza C. Aggregation of gramicidin A in phospholipid Langmuir-Blodgett monolayers. Biophys. J. 2002, 82, 3198-3206.
34. Diociaiuti M.; Ruspantini I.; Giordani C.; Bordi F.; Chistolini P. Distribution of GD3 in DPPC monolayers: a thermodynamic and atomic force microscopy combined study. Biophys. J. 2004, 86, 321-328.
35. Roberts G. Langmuir-Blodgett films; Plenum Press: New York, 1990.
36. Honig D.; Mobius J. Direct visualization of monolayers at the air-water interface by Brewster angle microscopy. J. Phys. Chem. 1991, 95, 4590-4592.
37. Leporatti S.; Brezesinski G.; Mohwald H. Coexistence of phases in monolayers of branched-chain phospholipids investigated by scanning force microscopy. Colloids Surfaces A 2000, 161, 159-171.
38. Kaganer V. M.; Mohawald H.; Dutta P. Structure and phase transitions in Langmuir monolayers. Rev. Mod. Phys. 1999, 71, 779-818.
39. Luckham P.; Wood J.; Froggatt S.; Swart R. The surface properties of gangliosides. J. Colloid Interface Sci. 1993, 156, 164-172.
40. Dynarowicz-Latka P.; Dhanabalan A.; Oliveira Jr. O. N. Modern physicochemical research on Langmuir monolayers. Adv. Colloid. Interface Sci. 2001, 91, 221-293.
41. Robenek M. J.; Schlattmann K.; Zimmer K. P.; Plenz G.; Troyer D.; Robenek H. Cholesterol transporter caveolin-1 transits the lipid bilayer during intracellular cycling. FASEB J. 2003, 17, 1940-1942.
42. Tainton K. M.; Smyth M. J.; Jackson J. T.; Cerruti L.; Jane S. M.; Darcy P. K.; Johnstone R. W. Mutational analysis of P-glycoprotein: suppression of caspase activation in the absence of ATP-dependent drug efflux. Cell Death Differ. 2004, 11, 1028-1037.